Occult cancer and unprovoked venous thromboembolism: What’s their relationship?
Occult cancers are generally advanced or metastatic tumors with unknown primary origin. In some cases, they are...
Most Read
An interview with Dr. Alok Khorana
We met with Dr. Alok Khorana in Berlin during the ISTH 2017 Congress. He could not hide his enthusiasm about the...
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
VTE in Palliative Care Patients: What do we know? A talk report from the 10th ICTHC
During the 10th ICTHIC, Professor Simon Noble (Cardiff University, UK) talked about the management of VTE in patients...
Managing antithrombotic medication in thrombocytopenia
Cancer is associated with an increased risk of venous but also arterial thrombosis1. Moreover, contemporary anticancer...
Incidental VTE: to treat or not to treat? – A debate from the 10th ICTHIC
During the 10th ICTHIC, Prof. Marcello di Nisio (University of Chieti, Italy) and Prof. Marc Carrier (Ottawa Hospital...
Arterial thromboembolism in patients with cancer and atrial fibrillation
Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...
The safety of DOACs to treat VTE in patients with brain tumors
Patients with primary and metastatic brain tumors have a high risk of venous thromboembolism (VTE), occurring in 20-30%...
An interview with Sam Schulman
Sam Schulman Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University,...
Cancer-associated thrombosis: mechanisms and risk factors
Blood clot generation in people with cancer follows a process distinct from the non-cancer population. Cancer tissue is...